Elliot Rosenstein, MD
Rheumatology · Summit, NJNPI 1174585145
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. E.r. Squibb & Sons, L.L.C. accounts for 61.3% of it on its own, with 30 other manufacturers making up the rest. Among rheumatology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 507 payments — averaging $198.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$62K
- AbbVie$16K
- Novartis$9K
- UCB, Inc.$7K
- Amgen$3K
- Johnson & Johnson$937
- plus $2K from 25 others
Across 8 payments — averaging $6120.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$35K
- GSK$13K
- AbbVie$1K
What the payments were for
- Consulting fees$51,20551%
- Speaking & faculty fees$33,46533%
- Travel & lodging$6,7207%
- Food & beverage$8,8669%
- Education$4380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 107 | $61,743 |
| AbbVie | 63 | $16,493 |
| Novartis | 63 | $9,156 |
| UCB, Inc. | 25 | $6,939 |
| Amgen(2 entities) | 72 | $3,028 |
| Johnson & Johnson | 37 | $937 |
| GSK | 31 | $538 |
| Pfizer | 19 | $299 |
| Sanofi | 11 | $186 |
| AstraZeneca(2 entities) | 10 | $169 |
| Lilly USA, LLC | 10 | $147 |
| Argenx US, Inc. | 1 | $137 |
| Boehringer Ingelheim | 9 | $134 |
| Radius Health, Inc. | 6 | $118 |
| Organon | 5 | $86 |
| Pacira Therapeutics, Inc. | 5 | $77 |
| Sobi, Inc | 4 | $65 |
| Bioventus LLC | 2 | $57 |
| Medexus Pharma, Inc. | 4 | $52 |
| Genentech USA, Inc. | 4 | $49 |
| Bristol Myers Squibb | 3 | $44 |
| Hikma Pharmaceuticals USA | 3 | $39 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 2 | $30 |
| Fresenius Kabi USA, LLC | 2 | $30 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORENCIA$8,679
- Rinvoq$8,429
- Bimzelx$2,975
- KRYSTEXXA$1,975
- VYVGART HYTRULO$137
How this compares
$100,695 in reported general payments places this provider in the 90th percentile of 234 rheumatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 26 | $218,013 |
| Hydroxychloroquine Sulfate | 76 | $3,272 |
| MethotrexateMethotrexate Sodium | 77 | $2,685 |
| Cevimeline Hcl | 16 | $1,785 |
| Leucovorin Calcium | 13 | $615 |
| Allopurinol | 20 | $405 |
| Duloxetine Hcl | 16 | $309 |
| Prednisone | 26 | $208 |
| Meloxicam | 20 | $186 |
| Cyclobenzaprine Hcl | 19 | $177 |
| Alendronate Sodium | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Summit
- Jeffrey GreenbergSummit$399K
- Neil KramerSummit$37K
- Krissy ChoiSummit$10K
- Lori CoxNew Brunswick$1.4M
- Richard HaddadRed Bank$1.1M
- Kiren SahniWest Long Branch$569K
- Steven GolombekDover$318K
- Nicholas ScarpaJersey City$281K
- Adrienne HollanderVoorhees$214K
- Edward AllegraRed Bank$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.